Aptose Biosciences
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch APTO and buy or sell other stocks, ETFs, and their options commission-free!About APTO
Aptose Biosciences, Inc. is a clinical-stage oncology company, which engages in the discovery, research, and development of anti-cancer therapies. Its product pipeline includes APTO-253, a small molecule that induces expression of the Kruppel-Like Factor 4 genes; and CG-806 a non-covalent small molecule therapeutic agent.
CEOWilliam G. Rice, PhD
CEOWilliam G. Rice, PhD
Employees13
Employees13
HeadquartersToronto, Ontario
HeadquartersToronto, Ontario
Founded1986
Founded1986
Employees13
Employees13
APTO Key Statistics
Market cap5.56M
Market cap5.56M
Price-Earnings ratio-0.03
Price-Earnings ratio-0.03
Dividend yield—
Dividend yield—
Average volume32.89K
Average volume32.89K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$24.30
52 Week high$24.30
52 Week low$0.6363
52 Week low$0.6363
People also own
Based on the portfolios of people who own APTO. This list is generated using Robinhood data, and it’s not a recommendation.